Wall Street RegretsThe regret calculator.

What if you'd held GYRE?

A $1,000 investment in Gyre Therapeutics, Inc. (GYRE) at the month-end close of 2006-04 would be worth $4.81 at the close of 2026-09 — -99.5% total return, dividends reinvested. The same $1,000 in the S&P 500, dividends reinvested, would be worth $8,676.

$1,000 since 2006$4.81Total return-99.5%Multiple0.00×CAGR-23.0%

Your scenario

Dates resolve to the nearest month-end close.
Leave empty for "held until today".
Invested at each month-end. Starts on the buy date.

Result

Worth$4.81Gain+$-995 (-99.5%)Multiple0.0×CAGR-23.0%

    If you'd bought $1,000 at the start of each year

    Value of $1,000 invested on January 1 of each year, held to 2026-09, dividends included.

    2006$4.812007$3.982008$4.362009$10.122010$1.722011$1.362012$6.472013$8.232014$8.692015$13.712016$59.862017$2882018$2062019$3562020$4132021$4452022$3,0892023$1,3942024$2672025$5672026$972

    Every year, $1,000 from 2006

    YearValue of $1,000Year return
    2006$1,000
    2007$913-8.7%
    2008$393-56.9%
    2009$2,309+487.1%
    2010$2,928+26.8%
    2011$615-79.0%
    2012$484-21.4%
    2013$459-5.3%
    2014$291-36.6%
    2015$66.54-77.1%
    2016$13.82-79.2%
    2017$19.33+39.9%
    2018$11.18-42.2%
    2019$9.65-13.7%
    2020$8.94-7.3%
    2021$1.29-85.6%
    2022$2.86+121.6%
    2023$14.92+422.0%
    2024$7.03-52.9%
    2025$4.10-41.7%
    2026$3.98-2.8%

    Best and worst month-end to buy

    The best single month-end close to have bought GYRE was 2022-04 ($1.17): $1,000 then is $5,853 today. The worst was 2011-02 ($5,457): $1,000 then is $1.26.

    FAQ

    What would $1,000 in GYRE be worth today?

    A $1,000 investment in Gyre Therapeutics, Inc. (GYRE) at the start of 2006 would be worth about $4.81 today, a total return of -99.5%. Dividends are reinvested in these figures.

    What were the best and worst years for GYRE?

    Gyre Therapeutics, Inc. (GYRE)'s strongest calendar year since 2006 was 2009, a +487.1% return — $1,000 held through that year became about $5,871 by year-end. Its weakest year was 2021, at -85.6%.

    Does the calculator include dividends and splits?

    Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.

    How much would $100 per month in GYRE have grown?

    Investing $100 at the end of every month since 2006-04 would have grown to about $10,614 on $24,600 invested.

    Did GYRE beat the S&P 500?

    Over the same period, $1,000 in the S&P 500 with dividends reinvested (the S&P 500 Total Return index) would be worth $8,676. GYRE trailed the S&P 500 by +99.9% in total return.

    Is this investment advice?

    No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.

    Methodology

    Gyre Therapeutics, Inc. (GYRE) historical total-return data from 2006-04 to 2026-09, reduced to month-end closes for the tables above.

    Returns use adjusted close prices — adjusted for stock splits and reinvested dividends, the same convention used by major brokerages. End-of-day and live prices come from EODHD; parts of the deep historical series are carried over from Yahoo Finance data. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (EODHD): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.

    Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.

    Full methodology →

    What if you'd held…

    Data: adjusted close prices via EODHD and Yahoo Finance. As of 2026-09-04. Not financial advice.